Mastercard Crypto Credential goes live with first peer-to-peer pilot transactions, adds new partners to the ecosystem

Financial giant Mastercard has recently made a significant move in the crypto space by launching its Crypto Credential Service. This service aims to simplify cross-border transactions and enhance the adoption of cryptocurrencies in the global financial system. With the Crypto Credential Service, Mastercard aims to provide a secure and efficient way for businesses and consumers to transact using digital assets. By leveraging blockchain technology, Mastercard aims to streamline cross-border payments, reducing transaction costs and increasing transaction speed. This new service is expected to benefit businesses and individuals who frequently engage in international transactions, as it eliminates the need for traditional intermediaries and reduces the complexity of cross-border payments. It also provides an added layer of security through the use of cryptographic technology. Mastercard’s entry into the crypto space further validates the growing acceptance and adoption of digital currencies. As one of the world’s leading payment processors, Mastercard’s move is likely to encourage other financial institutions to explore crypto-related services and solutions The launch of the Crypto Credential Service by Mastercard marks another significant milestone in the integration of cryptocurrencies into the mainstream financial system. It highlights the increasing recognition of the benefits and potential of digital assets in facilitating seamless and efficient cross-border transactions. https://preview.redd.it/vgantsl33f3d1.png?width=1056&format=png&auto=webp&s=cec60750e3dc09b24adbaa6d90901f77a4555157 submitted by /u/Lor1al [link] [comments]

This is going to be huge

Novo Nordisk shared another incredible study on semaglutide (the active ingredient in Ozempic) last week. It turned out that the drug (intended for diabetes) not only reduces appetite and obesity, but also treats chronic kidney disease. It also reduces the risk of heart attack, death from type 2 diabetes, and kidney failure. Source: https://finance.yahoo.com/news/novo-ozempic-slashes-risk-death-103000961.html If thematic investing in healthcare (i.e. investing in the growing trends shaping our future) is your long-term strategy, glad for you: https://preview.redd.it/2llnd2nsre3d1.png?width=1120&format=png&auto=webp&s=59faa8c6e5cc25fb9fa7a5238800f601298452db Healthcare sector representing +3.13% YTD Return and +68.58% 5-Year Return as of now includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies, as well as pharmaceutical retailers and companies which provide health information services. Largest companies in this sector showing the highest YTD return are Eli Lilly and Company (LLY), Merck & Co.,Inc. (MRK) and Danaher Corporation (DHR). submitted by /u/FXgram_ [link] [comments]